130 related articles for article (PubMed ID: 33419845)
1. Is Locally Advanced Head-Neck Cancer One More Candidate for Accelerated Hypofractionation?
Koukourakis IM; Zygogianni A; Kouloulias V; Kyrgias G; Panteliadou M; Nanos C; Abatzoglou I; Koukourakis MI
Anticancer Res; 2021 Jan; 41(1):467-475. PubMed ID: 33419845
[TBL] [Abstract][Full Text] [Related]
2. [Intensity Modulated Hyperfractionated Accelerated Radiotherapy to Treat Advanced Head and Neck Cancer - Predictive Factors of Overall Survival].
Cvek J; Knybel L; Stránský J; Matoušek P; Res O; Zeleník K; Otáhal B; Molenda L; Skácelíková E; Stieberová N; Čermáková Z; Feltl D
Klin Onkol; 2017; 30(4):282-288. PubMed ID: 28832174
[TBL] [Abstract][Full Text] [Related]
3. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized trial to compare accelerated (six fractions a week) radiotherapy against concurrent chemoradiotherapy (using conventional fractionation) in locally advanced head and neck cancers.
Gupta M; Mahajan R; Kaushal V; Seem RK; Gupta M; Bhattacharyya T
J Cancer Res Ther; 2015; 11(4):723-9. PubMed ID: 26881508
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
[TBL] [Abstract][Full Text] [Related]
6. Patterns of failure after postoperative intensity-modulated radiotherapy for locally advanced and recurrent head and neck cancer.
Ooishi M; Motegi A; Kawashima M; Arahira S; Zenda S; Nakamura N; Ariji T; Tokumaru S; Sakuraba M; Tahara M; Hayashi R; Akimoto T
Jpn J Clin Oncol; 2016 Oct; 46(10):919-927. PubMed ID: 27511989
[TBL] [Abstract][Full Text] [Related]
7. Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck.
Andrä C; Rauch J; Li M; Ganswindt U; Belka C; Saleh-Ebrahimi L; Ballhausen H; Nachbichler SB; Roeder F
Radiat Oncol; 2015 Jul; 10():140. PubMed ID: 26156022
[TBL] [Abstract][Full Text] [Related]
8. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
10. Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer.
Nuyts S; Dirix P; Hermans R; Poorten VV; Delaere P; Weltens C; Van den Bogaert W
Head Neck; 2007 Aug; 29(8):720-30. PubMed ID: 17315171
[TBL] [Abstract][Full Text] [Related]
11. Experience with intensity-modulated radiotherapy in the treatment of head and neck cancer.
Vanasek J; Odrazka K; Dusek L; Jarkovsky J; Michalek R; Chrobok V; Dolezel M; Kolarova I
J BUON; 2013; 18(4):970-6. PubMed ID: 24344025
[TBL] [Abstract][Full Text] [Related]
12. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
14. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
[TBL] [Abstract][Full Text] [Related]
15. A prospective, multicenter DAHANCA study of hyperfractionated, accelerated radiotherapy for head and neck squamous cell carcinoma.
Saksø M; Andersen E; Bentzen J; Andersen M; Johansen J; Primdahl H; Overgaard J; Eriksen JG
Acta Oncol; 2019 Oct; 58(10):1495-1501. PubMed ID: 31519130
[No Abstract] [Full Text] [Related]
16. Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.
Santa Cruz O; Tsoutsou P; Castella C; Khanfir K; Anchisi S; Bouayed S; Matzinger O; Ozsahin M
Oncology; 2018; 95(2):61-68. PubMed ID: 29895020
[TBL] [Abstract][Full Text] [Related]
17. Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results from a phase III randomized trial.
Corvò R; Benasso M; Sanguineti G; Lionetto R; Bacigalupo A; Margarino G; Pallestrini E; Merlano M; Vitale V; Rosso R
Cancer; 2001 Dec; 92(11):2856-67. PubMed ID: 11753959
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated Accelerated Chemo-radiotherapy (Chemo-HypoAR) With Cisplatin and Liposomal Doxorubicin for the Treatment of Patients With Uterine Sarcomas.
Domoxoudis S; Koukourakis IM; Giakzidis AG; Koukourakis MI
In Vivo; 2019; 33(5):1621-1624. PubMed ID: 31471414
[TBL] [Abstract][Full Text] [Related]
19. IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck.
Montejo ME; Shrieve DC; Bentz BG; Hunt JP; Buchman LO; Agarwal N; Hitchcock YJ
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e845-52. PubMed ID: 21167654
[TBL] [Abstract][Full Text] [Related]
20. Postoperative hypofractionated-accelerated radiotherapy (HypoAR) for locally advanced rectal cancer.
Koukourakis MI; Kavazis C; Giagtzidis A; Mamalis P; Tsaroucha A; Botaitis S; Giatromanolaki A; Pitiakoudis M
Jpn J Clin Oncol; 2022 May; 52(5):493-498. PubMed ID: 35079795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
